Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction
- DOI
- 10.3389/fcvm.2022.953211
- Published
- 2022-10-10
- Container
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcvm.2022.953211,
title = {Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction},
author = {Ana-Mishel Spiroski and Ian R. McCracken and Adrian Thomson and Marlene Magalhaes-Pinto and Mukesh K. Lalwani and Kathryn J. Newton and Eileen Miller and Cecile Bénézech and Patrick Hadoke and Mairi Brittan and Joanne C. Mountford and Abdelaziz Beqqali and Gillian A. Gray and Andrew H. Baker},
year = {2022},
journal = {Frontiers in Cardiovascular Medicine},
doi = {10.3389/fcvm.2022.953211},
url = {https://doi.org/10.3389/fcvm.2022.953211}
}RIS
TY - JOUR TI - Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction AU - Ana-Mishel Spiroski AU - Ian R. McCracken AU - Adrian Thomson AU - Marlene Magalhaes-Pinto AU - Mukesh K. Lalwani AU - Kathryn J. Newton AU - Eileen Miller AU - Cecile Bénézech AU - Patrick Hadoke AU - Mairi Brittan AU - Joanne C. Mountford AU - Abdelaziz Beqqali AU - Gillian A. Gray AU - Andrew H. Baker PY - 2022 JO - Frontiers in Cardiovascular Medicine DO - 10.3389/fcvm.2022.953211 UR - https://doi.org/10.3389/fcvm.2022.953211 ER -
APA
Spiroski, A., McCracken, I. R., Thomson, A., Magalhaes-Pinto, M., Lalwani, M. K., Newton, K. J., Miller, E., Bénézech, C., Hadoke, P., Brittan, M., Mountford, J. C., Beqqali, A., Gray, G. A., & Baker, A. H. (2022). Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2022.953211
Source records
- crossref · retrieved 2026-09-25T01:45:36.137Z